Max Planck researchers announce they have developed a new tool that can assist with precise genome editing in neurons.
A new study reports researchers have developed a new gene editing approach that may provide a new treatment avenue for Huntington's disease.
With the aid of CRISPR gene editing techniques, researchers have identified a new biomarker for Alzheimer's disease. The study reports a deficiency of the protein STIM1 could be implicated in the sporadic version of the neurodegenerative disease.
Researchers use gene editing to reverse cell degeneration and restore vision in mouse models of retinitis pigmentosa.
CRISPR technology and advanced screening techniques allow researchers to comb through over 1500 genetic combinations to find multiple drivers of glioblastoma brain cancer.
Researchers use CRISPR to modulate genes in order to reduce tissue damage and inflammation for people with neck and back pain.
A new study reports researchers have developed a quicker and more efficient method to alter mice genes with CRISPR-Cas9.
Stimulating microglial cells could delay the onset of some neurodegenerative diseases, researchers report.
Using CRISPR techniques, researchers have uncovered a genetic network linked to autism.
Researchers have successfully reduced some symptoms associated with fragile X syndrome in mice with the help of CRISPR-Cas 9 gene editing.
New application of DNA editing technique, CRISPR-Cas9, may open the door the new treatments for cancer and autism.
Researchers re-purposed CRISPR gene editing technology to study genes targeted by particular antibiotics. The study sheds light on how pharmacologists can improve existing antibiotics and develop new ones.
